Non-small-cell lung cancer is one of the leading causes of deaths from cancer worldwide.
Therefore, improvements in diagnostics and treatments are urgently needed. In this review …

Abstract Learning Objectives After completing this course, the reader will be able to: Identify
patients with non‐small cell lung cancer who may benefit from postoperative radiotherapy …

Objectives Stage III non-small cell lung cancer (NSCLC) describes a heterogeneous
population with disease presentation ranging from apparently resectable tumors with occult …

BACKGROUND: This study sought to ascertain whether induction‐concurrent radiotherapy
added to chemotherapy could improve the survival of patients undergoing surgery for stage …

Randomized trials were analyzed comparing surgery with definitive radiotherapy as local
curative treatment options within the framework of different multimodality treatments for …

Introduction: Our study aimed to evaluate whether pathologic complete response (pCR) in
early-stage non–small-cell lung cancer (NSCLC) after neoadjuvant chemotherapy resulted …

It was recently described that high FDG-uptake areas pre-radiotherapy largely correspond
with residual metabolic-active areas post-radiotherapy. Here, an independent prospective …

During recent years, the curative potential of radiotherapy versus surgery for esophageal
cancer was investigated in randomized trials. A PubMED®, Medline®, and Web of Science® …

Introduction Optimal management of clinical stage IIIA-N2 non–small-cell lung cancer
(NSCLC) is controversial. This study examines whether neoadjuvant chemoradiation plus …

Following definitive chemoradiation therapy, 24%-35% of patients with locally advanced non–
small cell lung cancer have recurrence. We aimed to evaluate the feasibility of salvage …